# Wall Street's Wildest Stock Showdowns: Bulls vs. Bears! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-10-01T02:39:00.717Z Source: https://newsyai.com/edition/854d387a-511b-47bd-989b-bb496b12a00b Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Wall Street's Most Polarizing Shitshows: 3 Stocks Where Bulls and Bears Are Still Throwing Hands (and Maybe Some Feces) — Fresh Edition, October 1, 2026** Futures mixed—Dow flat, Nasdaq mainlining the AI hype like it's the fountain of youth, crude oil bouncing like a caffeinated squirrel on a trampoline. Last round's Florida land bets, department-store turnaround drama, and data-analytics cloud fights? Yesterday's news. These three tickers have the Street more divided than a crypto bro at a family reunion. Elevated short interest across the board (flirting with 30-80%+ of float in recent screens, with days-to-cover that screams volatility potential), fresh short data, filings, and chatter only—no reruns. Bulls see structural tailwinds and squeeze fuel; bears see execution flops, dilution landmines, competition overhangs, and fading relevance. Then the first-principles hammer drops.[[1]](https://www.findmymoat.com/short-interest)[[2]](https://www.benzinga.com/short-interest/most-shorted) ### 1. RXRX (Recursion Pharmaceuticals) – AI Drug Discovery Darling or Biotech Cash Incinerator? RX RX carries notable short interest (around 30-35%+ in recent screens), as the AI-powered drug discovery biotech navigates clinical pipelines, partnerships, and the usual biotech cash-burn realities.[[1]](https://www.findmymoat.com/short-interest) **Bull Case (The "AI Will Crack Biology Like a Walnut, Pipeline Catalysts Incoming, and 'This Time the Machines Actually Deliver Cures' Crew)** Bulls highlight surging demand for AI-driven drug discovery, any progress on clinical candidates or big-pharma partnerships, long-term tailwinds from precision medicine and tech-biotech convergence, and potential for massive rebounds if data reads or trial updates accelerate. Some see it as a high-conviction platform play with short interest as squeeze ammo on positive updates or earnings beats. **Bear Case (The "Cash Burn Is Relentless, Competition from Bigger Players Crushes Margins, Dilution Looms, and 'Will It Ever Turn Data into Approved Drugs?' Crew)** Bears hammer ongoing cash-burn risks, execution challenges in translating AI hype to clinical success, history of biotech volatility, and doubts that the setup justifies exposure amid regulatory and competitive scrutiny. Short buildup reflects skepticism that hype justifies the risk amid financial and market realities.[[3]](https://www.chartmill.com/stock/markets/usa/screener/most-shorted-stocks) **My First-Principles Take**: Biotech value accrues to platforms with defensible tech/IP, scalable discovery engines, clear paths to positive free cash flow or milestone-driven margins, and moat edges in high-unmet-need areas—economics reward operational discipline and market adaptation over pure platform bets in a capital-intensive, regulatory-, and sentiment-sensitive field. RXRX has genuine tailwinds from AI-biotech tailwinds, but durable shareholder value only comes if pipelines convert without endless resets, differentiation holds vs. rivals, and operations turn discoveries into profits without perpetual volatility. The AI-drug bet is directionally exposed to tech-enabled R&D, yet it's an execution-, funding-, and sentiment-sensitive play prone to binary swings. At these short levels, volatility grenade—positive catalysts roast shorts; stumbles feed the fire. High-risk, high-reward for the bold. ### 2. VG (Venture Global) – LNG Export Powerhouse or Debt-Laden Execution Nightmare? VG sports sky-high short interest (often 78-80%+ of float in recent screens), as the LNG exporter navigates project timelines, global energy demand, and financing pressures.[[2]](https://www.benzinga.com/short-interest/most-shorted) **Bull Case (The "Global LNG Demand Is Structural, Projects Will Ramp, and 'This Time Execution Actually Delivers' Crew)** Bulls point to ongoing need for U.S. LNG exports amid energy security and transition dynamics, any progress on facility construction or offtake deals, long-term tailwinds from global demand growth, and potential for massive rebounds if macro energy spending or operational beats accelerate. Some see it as a high-conviction energy infrastructure play with short interest as squeeze ammo on positive updates or earnings beats. **Bear Case (The "Delays Keep Piling Up, Debt Load Bites Hard, Competition from Established Players Persists, and 'Will It Ever Monetize the Assets Properly?' Crew)** Bears hammer ongoing execution risks around project timelines and costs, risks around debt and capital needs, competition in the LNG space, and doubts that the setup justifies exposure amid macro energy and sentiment scrutiny. Short buildup reflects skepticism that hype justifies the risk amid operational and market realities.[[4]](https://www.benzinga.com/trading-ideas/movers/26/09/62004722/squeeze-watch-10-stocks-with-over-33-short-interest) **My First-Principles Take**: Energy infrastructure value accrues to players with defensible assets, scalable operations, clear paths to positive free cash flow or stable margins, and moat edges in high-demand regions—economics reward operational discipline and market adaptation over pure demand bets in a cyclical, capital-, regulatory-, and sentiment-sensitive field. VG has genuine tailwinds from LNG export growth, but durable shareholder value only comes if projects convert without endless resets, differentiation holds vs. peers, and operations turn capacity into profits without perpetual volatility. The LNG bet is directionally exposed to global energy needs, yet it's an execution-, leverage-, and sentiment-sensitive play prone to swings. At these short levels, volatility grenade—positive catalysts roast shorts; stumbles feed the fire. High-risk, high-reward for the bold. ### 3. CLSK (CleanSpark) – Bitcoin Mining/AI Data Center Hybrid or Energy-Cost and Competition Cash Furnace? CLSK features elevated short interest (around 40%+ in recent screens), as the Bitcoin miner pivots toward AI/HPC infrastructure amid crypto volatility and power-demand shifts.[[4]](https://www.benzinga.com/trading-ideas/movers/26/09/62004722/squeeze-watch-10-stocks-with-over-33-short-interest) **Bull Case (The "Bitcoin and AI Compute Demand Are Structural, Operations Scale Efficiently, and 'This Time Energy Assets Actually Deliver' Crew)** Bulls highlight ongoing need for Bitcoin mining and AI data-center capacity, any progress on expansion, efficiency gains, or energy deals, long-term tailwinds from crypto adoption and digital infrastructure growth, and potential for massive rebounds if macro spending or operational momentum accelerates. Some see it as a high-conviction crypto/AI infrastructure play with short interest as squeeze ammo on positive updates or earnings beats. **Bear Case (The "Energy Costs and Volatility Bite Hard, Competition from Newer Players Persists, Execution Risks Loom, and 'Will It Ever Be Truly Profitable in the New World?' Crew)** Bears hammer ongoing competitive pressures and energy-cost risks, risks around technology shifts and operational scaling, history of challenges in the mining space, and doubts that the setup justifies exposure amid macro and competitive scrutiny. Short buildup reflects skepticism that hype justifies the risk amid operational and market headwinds.[[5]](https://www.thetrading.tools/short-interest) **My First-Principles Take**: Digital infrastructure value accrues to operators with defensible energy assets, scalable and efficient operations, clear paths to positive free cash flow or stable margins, and moat edges in high-growth applications—economics reward operational discipline and market adaptation over pure demand bets in a competition-, energy-, and sentiment-sensitive field. CLSK has genuine tailwinds from Bitcoin/AI compute needs, but durable shareholder value only comes if expansions convert without endless resets, differentiation holds vs. rivals, and operations turn capacity into profits without perpetual volatility. The mining/AI bet is directionally exposed to digital transformation, yet it's an execution-, cost-, and sentiment-sensitive play prone to swings. At these short levels, volatility grenade—positive catalysts roast shorts; stumbles feed the fire. High-risk, high-reward for the bold. There you have it—three fresh brawls proving disagreement is the market's favorite drug. Do your own damn homework, size like an adult, and remember: the tape stays irrational longer than your margin account can breathe. Sources pulled from latest short interest data (e.g., via TipRanks, Benzinga, Find My Moat, and related screens), company filings/press releases, analyst notes, and options flow as of late September/early October 2026. Trade responsibly, you magnificent animals.